Cochrane COVID-19 Study Register
Study record
NCT05132972First Published: 2021 Nov 24Updated Date: 2021 Nov 24

Efficacy and Safety of Normoxic Allogenic Umbilical Cord Mesenchymal Stem Cells Administered as Adjuntive Treatment to Standard Treatment in Severe Patients With COVID-19

  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
Reference record

Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients

Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia
First Published (first received 2021 November 24)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT05132972)
Trial registry record
No Results
This study is conducted to assess the efficacy and safety of stem cells as adjunctive treatment for severe COVID-19 patients. Here, we want to study whether the administration of mesenchymal stem cells are safe and able to relieve some of the COVID-19 symptoms